ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Celularity Inc. Warrant
0.0075
-0.0007
-8.54%
成交量：
1,000.00
成交額：
7.50
市值：
17.96萬
市盈率：
0.00
高：
0.0075
開：
0.0075
低：
0.0075
收：
0.0082
52周最高：
0.0984
52周最低：
0.0065
股本：
2,394.92萬
流通股本：
2,394.92萬
量比：
0.47
換手率：
0.00%
股息：
- -
股息率：
- -
每股收益(TTM):
-3.3352
淨資產收益率：
-6367.24%
總資產收益率：
-25.03%
市淨率：
-0.01
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
Celularity重申與Nexgel戰略商業化合作 聚焦開發生物材料產品線並拓展510(K)通道新機遇
美股速递
·
03/12
Celularity簽署3500萬美元戰略許可協議，鞏固資本實力推進長壽戰略
美股速递
·
03/10
Celularity Inc. 將生物材料業務相關人員轉移至商業合作伙伴；並宣佈進一步裁員
美股速递
·
03/10
Celularity Inc. 組織架構重組降低運營開支，聚焦長壽療法領域
美股速递
·
03/10
Celularity Inc C/Wts 16/07/2026 (To Pur Com)股價重挫25.00% 市值跌41.3萬美元
市场透视
·
02/13
Celularity Inc C/Wts 16/07/2026 (To Pur Com)盤中異動 快速下挫21.62%報0.015美元
市场透视
·
01/29
Celularity Inc C/Wts 16/07/2026 (To Pur Com)盤中異動 快速跳水10.05%報0.018美元
市场透视
·
01/14
Celularity Inc C/Wts 16/07/2026 (To Pur Com)盤中異動 早盤股價大漲8.48%
市场透视
·
01/09
Celularity Inc C/Wts 16/07/2026 (To Pur Com)盤中異動 早盤急速跳水18.89%
市场透视
·
2025/12/26
Celularity Inc C/Wts 16/07/2026 (To Pur Com)盤中異動 快速上漲6.15%報0.019美元
市场透视
·
2025/12/22
Celularity Inc C/Wts 16/07/2026 (To Pur Com)盤中異動 快速拉升9.67%
市场透视
·
2025/11/18
Celularity Inc C/Wts 16/07/2026 (To Pur Com)盤中異動 大幅下挫17.34%
市场透视
·
2025/11/04
Celularity宣佈同行評審發表2期臨床試驗結果，證明人胎盤來源細胞(Pda-002)治療合併外周動脈疾病的糖尿病足潰瘍的安全性和有效性
美股速递
·
2025/10/14
Celularity Inc C/Wts 16/07/2026 (To Pur Com)盤中異動 股價大漲5.27%報0.035美元
市场透视
·
2025/10/13
Celularity Inc C/Wts 16/07/2026 (To Pur Com)盤中異動 下午盤股價大跌7.44%
市场透视
·
2025/10/09
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/CELUW/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CELUW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CELUW\",,,,,undefined,":{"symbol":"CELUW","market":"US","secType":"STK","nameCN":"Celularity Inc. Warrant","latestPrice":0.0075,"timestamp":1774468800000,"preClose":0.0082,"halted":0,"volume":1000,"delay":0,"changeRate":-0.0853658536585367,"floatShares":23949233,"shares":23949233,"eps":-3.3352,"marketStatus":"盤後交易","change":-0.0007,"latestTime":"03-25 16:49:31 EDT","open":0.0075,"high":0.0075,"low":0.0075,"amount":7.5,"amplitude":0,"askPrice":0.0099,"askSize":1943,"bidPrice":0.004,"bidSize":31,"shortable":3,"etf":0,"ttmEps":-3.3352,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1774483200000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":0.0082,"volumeRatio":0.467508},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CELUW\",,,,,undefined,":{"symbol":"CELUW","floatShares":23949233,"roa":"-25.03%","roe":"-6367.24%","lyrEps":0,"volumeRatio":0.467508,"shares":23949233,"dividePrice":0,"high":0.0075,"amplitude":0,"preClose":0.0082,"low":0.0075,"week52Low":0.0065,"pbRate":"-0.01","psRate":"0.00","week52High":0.0984,"institutionHeld":0,"latestPrice":0.0075,"committee":-0.968592,"eps":-3.3352,"divideRate":0,"volume":1000,"delay":0,"ttmEps":-3.3352,"open":0.0075,"prevYearClose":0.01625,"prevWeekClose":0.008,"prevMonthClose":0.007,"prevQuarterClose":0.0163,"fiveDayClose":0.008,"twentyDayClose":0.0087,"sixtyDayClose":0.02},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CELUW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CELUW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CELUW\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CELUW\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1141502892","title":"Celularity重申與Nexgel戰略商業化合作 聚焦開發生物材料產品線並拓展510(K)通道新機遇","url":"https://stock-news.laohu8.com/highlight/detail?id=1141502892","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141502892?lang=zh_tw&edition=fundamental","pubTime":"2026-03-12 20:32","pubTimestamp":1773318773,"startTime":"0","endTime":"0","summary":"生物技术公司Celularity Inc.近日重申与NEXGEL, INC.达成的战略商业化合作。该合作将依托双方现有商业化产品体系，共同构建生物材料领域的产品矩阵，同时积极开拓通过510监管通道的新产品机会。此次合作将整合Celularity在细胞疗法领域的创新技术与Nexgel的水凝胶材料平台优势，旨在加速创伤修复、组织再生等医疗场景的生物材料解决方案落地。合作双方表示，这一战略伙伴关系将强化其在生物材料市场的竞争力，为医疗行业提供更全面的产品组合。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CELUW","BK4198","BK4139","CELU","NXGL"],"gpt_icon":0},{"id":"1104849797","title":"Celularity簽署3500萬美元戰略許可協議，鞏固資本實力推進長壽戰略","url":"https://stock-news.laohu8.com/highlight/detail?id=1104849797","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104849797?lang=zh_tw&edition=fundamental","pubTime":"2026-03-10 20:31","pubTimestamp":1773145912,"startTime":"0","endTime":"0","summary":"生物科技公司Celularity Inc.（纳斯达克代码：CELU）近日达成一项总额3500万美元的战略性许可协议。该交易显著增强了公司的资本状况，为其专注于延长人类健康寿命的核心战略提供了强有力的资金支持。此次合作不仅为Celularity带来了可观的非稀释性资金，更将加速其基于胎盘源性干细胞技术的创新疗法研发进程，标志着公司在实现其“长寿战略”的征途上迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CELU","CELUW"],"gpt_icon":0},{"id":"1120331482","title":"Celularity Inc. 將生物材料業務相關人員轉移至商業合作伙伴；並宣佈進一步裁員","url":"https://stock-news.laohu8.com/highlight/detail?id=1120331482","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120331482?lang=zh_tw&edition=fundamental","pubTime":"2026-03-10 20:31","pubTimestamp":1773145911,"startTime":"0","endTime":"0","summary":"生物技术公司Celularity Inc.近日宣布了一项重要人事调整。公司决定，将与其生物材料业务活动相关的员工团队，整体转移至一家商业合作伙伴处。这一举措旨在优化公司资源配置，聚焦核心研发领域。\n与此同时，Celularity Inc. 还宣布了进一步的裁员计划。这是公司为提升运营效率、实现长期战略目标而采取的结构性调整的一部分。此次人员变动预计将使公司的组织架构更为精简高效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CELU","BK4139","CELUW"],"gpt_icon":0},{"id":"1130950545","title":"Celularity Inc. 組織架構重組降低運營開支，聚焦長壽療法領域","url":"https://stock-news.laohu8.com/highlight/detail?id=1130950545","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130950545?lang=zh_tw&edition=fundamental","pubTime":"2026-03-10 20:31","pubTimestamp":1773145874,"startTime":"0","endTime":"0","summary":"生物技术公司Celularity Inc.近期宣布了一项重要的组织架构重组计划。此举旨在通过优化内部结构，显著降低公司的运营成本。\n重组后的Celularity将更专注于其核心战略方向——长寿疗法的研发。这一调整预示着公司资源将更集中地投入到具有巨大潜力的抗衰老治疗领域，以推动其长期增长目标。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CELU","BK4139","CELUW"],"gpt_icon":0},{"id":"2611318251","title":"Celularity Inc C/Wts 16/07/2026 (To Pur Com)股價重挫25.00% 市值跌41.3萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2611318251","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611318251?lang=zh_tw&edition=fundamental","pubTime":"2026-02-13 00:49","pubTimestamp":1770914942,"startTime":"0","endTime":"0","summary":"北京时间2026年02月13日00时49分，Celularity Inc C/Wts 16/07/2026 股票出现异动，股价大幅跳水25.00%。Celularity Inc C/Wts 16/07/2026 股票所在的生物技术行业中，整体跌幅为0.26%。Celularity Inc C/Wts 16/07/2026 公司简介：Celularity Inc 是一家临床阶段的生物技术公司，开发现成的胎盘来源的异体细胞疗法，包括转基因和未修饰的NK细胞，工程T细胞和间充质样粘附基质细胞，针对癌症，免疫，感染性和退行性疾病的适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213004902a6f42a59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213004902a6f42a59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CELUW"],"gpt_icon":0},{"id":"2607405717","title":"Celularity Inc C/Wts 16/07/2026 (To Pur Com)盤中異動 快速下挫21.62%報0.015美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607405717","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607405717?lang=zh_tw&edition=fundamental","pubTime":"2026-01-29 23:36","pubTimestamp":1769700962,"startTime":"0","endTime":"0","summary":"北京时间2026年01月29日23时36分，Celularity Inc C/Wts 16/07/2026 股票出现波动，股价急速下挫21.62%。Celularity Inc C/Wts 16/07/2026 股票所在的生物技术行业中，整体涨幅为0.16%。Celularity Inc C/Wts 16/07/2026 公司简介：Celularity Inc 是一家临床阶段的生物技术公司，开发现成的胎盘来源的异体细胞疗法，包括转基因和未修饰的NK细胞，工程T细胞和间充质样粘附基质细胞，针对癌症，免疫，感染性和退行性疾病的适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129233602a46562e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129233602a46562e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CELUW"],"gpt_icon":0},{"id":"2603654614","title":"Celularity Inc C/Wts 16/07/2026 (To Pur Com)盤中異動 快速跳水10.05%報0.018美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603654614","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603654614?lang=zh_tw&edition=fundamental","pubTime":"2026-01-14 01:23","pubTimestamp":1768324981,"startTime":"0","endTime":"0","summary":"北京时间2026年01月14日01时23分，Celularity Inc C/Wts 16/07/2026 股票出现异动，股价大幅下跌10.05%。截至发稿，该股报0.018美元/股，成交量200股，换手率0.00%，振幅0.00%。Celularity Inc C/Wts 16/07/2026 股票所在的生物技术行业中，整体跌幅为0.07%。Celularity Inc C/Wts 16/07/2026 公司简介：Celularity Inc 是一家临床阶段的生物技术公司，开发现成的胎盘来源的异体细胞疗法，包括转基因和未修饰的NK细胞，工程T细胞和间充质样粘附基质细胞，针对癌症，免疫，感染性和退行性疾病的适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114012301a4bfbd6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114012301a4bfbd6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CELUW"],"gpt_icon":0},{"id":"2602589361","title":"Celularity Inc C/Wts 16/07/2026 (To Pur Com)盤中異動 早盤股價大漲8.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602589361","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602589361?lang=zh_tw&edition=fundamental","pubTime":"2026-01-09 22:45","pubTimestamp":1767969901,"startTime":"0","endTime":"0","summary":"北京时间2026年01月09日22时45分，Celularity Inc C/Wts 16/07/2026 股票出现波动，股价大幅拉升8.48%。Celularity Inc C/Wts 16/07/2026 股票所在的生物技术行业中，整体涨幅为1.06%。Celularity Inc C/Wts 16/07/2026 公司简介：Celularity Inc 是一家临床阶段的生物技术公司，开发现成的胎盘来源的异体细胞疗法，包括转基因和未修饰的NK细胞，工程T细胞和间充质样粘附基质细胞，针对癌症，免疫，感染性和退行性疾病的适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109224501a707d0ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109224501a707d0ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CELUW"],"gpt_icon":0},{"id":"2594161082","title":"Celularity Inc C/Wts 16/07/2026 (To Pur Com)盤中異動 早盤急速跳水18.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594161082","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594161082?lang=zh_tw&edition=fundamental","pubTime":"2025-12-26 23:07","pubTimestamp":1766761621,"startTime":"0","endTime":"0","summary":"北京时间2025年12月26日23时07分，Celularity Inc C/Wts 16/07/2026 股票出现异动，股价大幅下挫18.89%。Celularity Inc C/Wts 16/07/2026 股票所在的生物技术行业中，整体跌幅为0.24%。Celularity Inc C/Wts 16/07/2026 公司简介：Celularity Inc 是一家临床阶段的生物技术公司，开发现成的胎盘来源的异体细胞疗法，包括转基因和未修饰的NK细胞，工程T细胞和间充质样粘附基质细胞，针对癌症，免疫，感染性和退行性疾病的适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251226230701a6d328e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251226230701a6d328e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CELUW"],"gpt_icon":0},{"id":"2593918014","title":"Celularity Inc C/Wts 16/07/2026 (To Pur Com)盤中異動 快速上漲6.15%報0.019美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593918014","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593918014?lang=zh_tw&edition=fundamental","pubTime":"2025-12-22 23:05","pubTimestamp":1766415902,"startTime":"0","endTime":"0","summary":"北京时间2025年12月22日23时05分，Celularity Inc C/Wts 16/07/2026 股票出现波动，股价急速拉升6.15%。Celularity Inc C/Wts 16/07/2026 股票所在的生物技术行业中，整体涨幅为0.68%。Celularity Inc C/Wts 16/07/2026 公司简介：Celularity Inc 是一家临床阶段的生物技术公司，开发现成的胎盘来源的异体细胞疗法，包括转基因和未修饰的NK细胞，工程T细胞和间充质样粘附基质细胞，针对癌症，免疫，感染性和退行性疾病的适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222230502a6c20356&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222230502a6c20356&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CELUW"],"gpt_icon":0},{"id":"2584558993","title":"Celularity Inc C/Wts 16/07/2026 (To Pur Com)盤中異動 快速拉升9.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584558993","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584558993?lang=zh_tw&edition=fundamental","pubTime":"2025-11-18 23:55","pubTimestamp":1763481302,"startTime":"0","endTime":"0","summary":"北京时间2025年11月18日23时55分，Celularity Inc C/Wts 16/07/2026 股票出现波动，股价大幅上涨9.67%。Celularity Inc C/Wts 16/07/2026 股票所在的生物技术行业中，整体跌幅为0.25%。Celularity Inc C/Wts 16/07/2026 公司简介：Celularity Inc 是一家临床阶段的生物技术公司，开发现成的胎盘来源的异体细胞疗法，包括转基因和未修饰的NK细胞，工程T细胞和间充质样粘附基质细胞，针对癌症，免疫，感染性和退行性疾病的适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118235502a7024760&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118235502a7024760&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CELUW"],"gpt_icon":0},{"id":"2581796980","title":"Celularity Inc C/Wts 16/07/2026 (To Pur Com)盤中異動 大幅下挫17.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581796980","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581796980?lang=zh_tw&edition=fundamental","pubTime":"2025-11-04 22:48","pubTimestamp":1762267737,"startTime":"0","endTime":"0","summary":"北京时间2025年11月04日22时48分，Celularity Inc C/Wts 16/07/2026 股票出现异动，股价大幅下跌17.34%。Celularity Inc C/Wts 16/07/2026 股票所在的生物技术行业中，整体跌幅为0.25%。Celularity Inc C/Wts 16/07/2026 公司简介：Celularity Inc 是一家临床阶段的生物技术公司，开发现成的胎盘来源的异体细胞疗法，包括转基因和未修饰的NK细胞，工程T细胞和间充质样粘附基质细胞，针对癌症，免疫，感染性和退行性疾病的适应症。该公司的大部分收入来自临床级生物样本库部门。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110422485794eecbf0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110422485794eecbf0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CELUW"],"gpt_icon":0},{"id":"1172520236","title":"Celularity宣佈同行評審發表2期臨床試驗結果，證明人胎盤來源細胞(Pda-002)治療合併外周動脈疾病的糖尿病足潰瘍的安全性和有效性","url":"https://stock-news.laohu8.com/highlight/detail?id=1172520236","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172520236?lang=zh_tw&edition=fundamental","pubTime":"2025-10-14 20:45","pubTimestamp":1760445936,"startTime":"0","endTime":"0","summary":"Celularity宣布同行评审发表2期临床试验结果，证明人胎盘来源细胞(Pda-002)治疗合并外周动脉疾病的糖尿病足溃疡的安全性和有效性","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CELUW","CELU","BK4139"],"gpt_icon":0},{"id":"2575252362","title":"Celularity Inc C/Wts 16/07/2026 (To Pur Com)盤中異動 股價大漲5.27%報0.035美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575252362","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575252362?lang=zh_tw&edition=fundamental","pubTime":"2025-10-13 21:33","pubTimestamp":1760362394,"startTime":"0","endTime":"0","summary":"北京时间2025年10月13日21时33分，Celularity Inc C/Wts 16/07/2026 股票出现异动，股价快速拉升5.27%。Celularity Inc C/Wts 16/07/2026 股票所在的生物技术行业中，整体跌幅为0.46%。Celularity Inc C/Wts 16/07/2026 公司简介：Celularity Inc 是一家临床阶段的生物技术公司，开发现成的胎盘来源的异体细胞疗法，包括转基因和未修饰的NK细胞，工程T细胞和间充质样粘附基质细胞，针对癌症，免疫，感染性和退行性疾病的适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251013213314a6b731c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251013213314a6b731c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CELUW"],"gpt_icon":0},{"id":"2574152321","title":"Celularity Inc C/Wts 16/07/2026 (To Pur Com)盤中異動 下午盤股價大跌7.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574152321","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574152321?lang=zh_tw&edition=fundamental","pubTime":"2025-10-09 01:41","pubTimestamp":1759945261,"startTime":"0","endTime":"0","summary":"北京时间2025年10月09日01时41分，Celularity Inc C/Wts 16/07/2026 股票出现异动，股价大幅下挫7.44%。Celularity Inc C/Wts 16/07/2026 股票所在的生物技术行业中，整体涨幅为0.63%。Celularity Inc C/Wts 16/07/2026 公司简介：Celularity Inc 是一家临床阶段的生物技术公司，开发现成的胎盘来源的异体细胞疗法，包括转基因和未修饰的NK细胞，工程T细胞和间充质样粘附基质细胞，针对癌症，免疫，感染性和退行性疾病的适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251009014101a45759d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251009014101a45759d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XBIOW","CELUW"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":15,"code":"91000000","status":"200"}]}}